Successful treatment of early onset Epstein-Barr virus-negative T-cell lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation with histone deacetylase inhibitor chidamide.

Authors	Hua-Rui Fu, Ting-Ting Yang, Yan-Min Zhao, Ya-Min Tan, Qi-Qi Gao, He Huang, Ji-Min Shi
Journal	Chinese medical journal (Chin Med J (Engl)) Vol. 134 Issue 22 Pg. 2756-2758 (04 14 2021) ISSN: 2542-5641 [Electronic] China
PMID	34845998 (Publication Type: Letter)
Chemical References	Aminopyridines Benzamides Histone Deacetylase Inhibitors N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
Topics	Aminopyridines Benzamides Epstein-Barr Virus Infections (drug therapy) Hematopoietic Stem Cell Transplantation Herpesvirus 4, Human Histone Deacetylase Inhibitors (therapeutic use) Humans Lymphoproliferative Disorders (drug therapy) T-Lymphocytes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!